Posts filtered by tags: US National Institutes of Health[x]


US launches study of long Covid in tens of thousands of patients

The US National Institutes of Health said Wednesday it's starting a $470 million study to try to understand what's become known as long Covid—the long-term, sometimes serious effects of Covid-19.
Tags: US, Cnn, US National Institutes of Health

400,000 people are infected each year with coronaviruses carried by bats, an early study suggests. Researchers say the data could help prevent future pandemics.

A team of researchers set up a net to catch bats at the Khao Chong Pran Cave on September 12, 2020 in Ratchaburi, Thailand during a mission to understand the coronavirus's origins. Lauren DeCicca/Getty Coronaviruses from bats could infect 407,422 people each year, a study said. The findings could help target areas for surveillance and stop human virus outbreaks, they said. About 478 million people live in regions where the bats are, the researchers said. See more stories on Insider...
Tags: Health, Science, News, China, US, Trends, Bloomberg, Healthcare, Myanmar, Bat, Holmes, University of Sydney, US National Institutes of Health, Pandemic, Lauren DeCicca Getty, Coronavirus

The US is studying how COVID-19 vaccines work in people with suppressed immune systems - after research suggested they develop fewer antibodies from the shots

Emanuele Cremaschi / Contributor/Getty Images The US National Institutes of Health will analyze study participants' T cells and antibodies. It's unclear whether people with immune disorders generate a robust immune response to the available the COVID-19 vaccines. A study found that those taking immunosuppressants were less likely to have developed a high level of antibodies after a jab. See more stories on Insider's business page. The National Institutes of Health has launch...
Tags: Cdc, US, Trends, Johnson Johnson, Johns Hopkins University, The National Institutes of Health, US National Institutes of Health, Dorry Segev, COVID, Centers for Diseases Control and Prevention, the NIH, Rochelle Walensky, Catherine Schuster Bruce, Pfizer BioNTech Moderna, Kelsie Sandoval, Emanuele Cremaschi

Discovery of a third T cell lineage

In a paper published today in Science, an international team of scientists at the University of New Mexico (US), Monash University (Australia), and the US National Institutes of Health, has defined a novel T cell lineage, called γμ T cells, found only in marsupials (e.g. kangaroos and opossums) and monotremes (e.g. duckbill platypus).
Tags: Science, US National Institutes of Health

A woman who had crippling long COVID for 8 months says it vanished after getting vaccinated. There is no clear scientific reason why.

A woman gets a shot of COVID-19 vaccine. She is not Arianna Eisenberg, the woman in this story. REUTERS/Lucy Nicholson Arianna Eisenberg says her long COVID symptoms were gone after two vaccine shots, the Washington Post reported. Others have reported that vaccination alleviated long COVID symptoms. Scientists don't understand the phenomenon, but one has ideas of how it could work. See more stories on Insider's business page. A woman who had long COVID said her symptoms were gone ...
Tags: Facebook, Post, UK, Science, Congress, Washington Post, Trends, News UK, Columbia University, University of Bristol, Symptoms, Kaiser Health News, Huffington Post, Philadelphia Inquirer, Eisenberg, US National Institutes of Health

Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them

Dr. Daniel Kastner of the US National Institutes of Health identified 16 rare autoinflammatory genetic disorders and found effective treatments for at least 12 of them. In the process, he established a whole new field of medicine.
Tags: Cnn, US National Institutes of Health, Daniel Kastner

Moderna is designing a new version of its COVID-19 shot to fight the variant first found in South Africa

Moderna's COVID-19 vaccine was the second to be authorized for emergency use in the US. Radek Mica /AFP via Getty Images Moderna says its current coronavirus shot probably protects against two fast-spreading variants. But the shot showed lower levels of antibodies in lab testing against one of them. The company is now tailoring a version of its vaccine to that strain, first found in South Africa. Visit Business Insider's homepage for more stories. Moderna's coronavirus vaccine is proba...
Tags: Europe, UK, Science, Massachusetts, US, Trends, South Africa, Healthcare, Fda, Pfizer, Biotech, Anthony Fauci, Polaroid, Cnbc, David Morse, Fauci

Moderna is working on a new version of its COVID-19 shot designed to fight the South African variant

Moderna's COVID-19 vaccine is one of two that have been authorized for emergency use to fight the pandemic across the US. The other vaccine available is from Pfizer. Radek Mica /AFP via Getty Images Moderna said its current coronavirus shot can probably protect people against variants of the disease first found in South Africa and the UK. But the shot showed lower levels of antibodies in lab testing against the South African variant.  Moderna is now developing a new version of its vacc...
Tags: UK, Science, Washington Post, Massachusetts, Nbc News, US, Trends, South Africa, Healthcare, Biotech, Anthony Fauci, Polaroid, Fauci, US National Institutes of Health, Breaking, Moderna

Photos show the first batches of Moderna's coronavirus vaccine being packaged and shipped across the US

Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped. AP Photo/Paul Sancya, Pool The Food and Drug Administration on Friday granted an emergency use authorization for the COVID-19 vaccine developed by the biotech firm Moderna and the US National Institutes of Health. The two-shot Moderna/NIH vaccine was approximately 94.5% effective at preventing COVID-19 in a large clinical trial. The FDA last week issued the same authorization for the vaccine created by Pfizer and Bio...
Tags: News, Mississippi, US, Trends, Joe Biden, Healthcare, Fda, Pfizer, Centers For Disease Control And Prevention, McKesson, US Food and Drug Administration, Vivek Murthy, US National Institutes of Health, Olive Branch Mississippi, Moderna, Andrew Dunn

The US just authorized Moderna's coronavirus vaccine, making millions more doses available to help curb the pandemic

Moderna; Samantha Lee/Business Insider US regulators have authorized a second coronavirus vaccine for emergency use.  This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna's vaccine is easier to store and transport than Pfizer's COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year's end.  The authorizati...
Tags: Health, Science, News, China, Massachusetts, Russia, US, Trends, United States, Healthcare, Astrazeneca, Fda, Pfizer, University of Oxford, Anthony Fauci, Low

Peer-reviewed scientific study claims COVID-19 is embedded in our DNA, can be cured with magical amulets, also Stonehenge

This news comes from a peer-reviewed paper in the academic journal Science of the Total Environment, based on a study that was, allegedly, supported through funding provided by the US National Institutes of Health. Mark Hay from The Daily Beast sums it up perfectly: The coronavirus may not really be all that novel. — Read the rest
Tags: Post, Science, News, Stonehenge, DNA tests, Mark Hay, US National Institutes of Health, Seems Legit, Science of the Total Environment, Science Art Magic, Coronavirus, COVID-19, Amulets, Genetic Databases, Magical Amulets

SoulCycle's top instructors had sex with clients, 'fat-shamed' coworkers, and used homophobic and racist language, insiders say

Hello everyone! Welcome to this weekly roundup of Business Insider stories from co-Editor in Chief Matt Turner. Subscribe here to get this newsletter in your inbox every Sunday.Read on for more on SoulCycle's top instructors mistreating staff, Moderna's research revolution, and Google CEO Sundar Pichai's leadership shift. Bryan R. Smith/Getty; BFA; Olivia Atherton; Skye Gould/Business Insider Hello!We now have two promising coronavirus vaccines, with Moderna's promising results this week...
Tags: Google, Amazon, Hollywood, California, France, China, Trends, Nike, Palo Alto, Larry Page, Atlantic, Sergey Brin, Retail, Silicon Valley, Graham, Pfizer

Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic

Moderna Therapeutics seen during COVID-19 in Massachusetts Reuters Moderna's experimental coronavirus vaccine was highly effective at preventing COVID-19, the Massachusetts biotech company said on Monday. The finding comes from a 30,000-person study that compared volunteers who got a two-dose regimen of Moderna's shot to ones who got a placebo. The vaccine was shown to be 94.5% effective in a preliminary analysis. The announcement closely follows similar news from a rival vaccine program b...
Tags: Health, Science, News, Ipo, Massachusetts, US, Trends, Healthcare, Fda, Pfizer, Biotech, Zika, Johnson Johnson, US Food and Drug Administration, Sanofi, Cambridge Massachusetts

Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.

FILE PHOTO: A vial of redesivir Reuters Several leading coronavirus clinical trials are focusing on testing experimental combinations of medicine to treat COVID-19. These studies are building on top of the early success of remdesivir, an antiviral drug developed by Gilead Sciences that helped hospitalized COVID-19 patients recover modestly faster. On Friday, the US National Institutes of Health launched a massive study that will test three drugs seeking to tamp down a runaway immune respon...
Tags: Health, Science, News, US, Trends, Indianapolis, Austin, Healthcare, World Health Organization, Nih, Collins, Antiviral, Financial Times, Mayo Clinic, Reuters, Bristol Myers Squibb

Remdesivir, the only antiviral authorized for COVID-19 in the US, did not improve chances of survival in a massive WHO study

Remdesivir has an emergency-use authorization for all hospitalized patients with COVID-19 in the US. Reuters A World Health Organization study of more than 2,750 COVID-19 patients suggested that the antiviral drug remdesivir had "little or no effect" on survival. The Solidarity trial, which has not yet been peer-reviewed, found remdesivir did not "substantially affect mortality," reduce the need to ventilate patients, or shorten hospital stays. President Donald Trump received the antiviral...
Tags: US, Trends, European Union, Food And Drug Administration, Who, World Health Organization, Donald Trump, Nih, Solidarity, Gilead, US National Institutes of Health, COVID, Kate Duffy, US Reuters A World Health Organization, WHO Solidarity

Nobel prize in medicine awarded to trio for work on hepatitis C

Harvey Alter, Michael Houghton, Charles Rice share 10m Swedish kronor prizeTwo Americans and a British scientist have been awarded the Nobel prize in medicine for their groundbreaking work on blood-borne hepatitis, a health problem that causes cirrhosis and liver cancer around the world.Harvey J Alter at the US National Institutes of Health in Maryland, Charles M Rice from Rockefeller University in New York, and Michael Houghton, a British virologist at the University of Alberta in Canada, disco...
Tags: New York, Science, Medicine, UK News, Canada, Awards and prizes, People in science, Nobel prizes, Science prizes, University Of Alberta, Nobel Prize In Literature, Rockefeller University, US National Institutes of Health, Maryland Charles, C. Harvey, Michael Houghton Charles Rice

A leading coronavirus-treatment researcher says Trump shouldn't take hydroxychloroquine as a COVID-19 treatment. Here are his best options.

Scott Olson/Getty Images A top hydroxychloroquine researcher recommended against President Donald Trump taking the pills as a COVID-19 treatment.  "I would not give him magic beans, so I would not give him hydroxychloroquine," Dr. David Boulware said Friday morning in a phone interview with Business Insider. "This is not going to be an effective therapy." Boulware is an infectious-disease researcher at the University of Minnesota. Earlier this year, he led clinical trials that found hydro...
Tags: Politics, Science, White House, Trends, Healthcare, Fda, Donald Trump, Nih, Trump, Melania Trump, Gilead Sciences, Raymond James, US Food and Drug Administration, University of Minnesota, Scott Olson Getty, Eli Lilly

Survey finds American support for human-animal chimera research

In September 2015, the US National Institutes of Health placed a funding moratorium on research that involves introducing human pluripotent stem cells into animal embryos. To assess attitudes on human-animal chimeric embryo research, investigators conducted a survey among 430 Americans. The results of the survey, which found that 82% of people are supportive of at least some parts of this research, appear October 1 in the journal Stem Cell Reports.
Tags: Science, US National Institutes of Health

Coronavirus live news: US 'won't cooperate with WHO on vaccine'

White House condemns ‘corrupt’ international work on treatment but antibody study offers vaccine hope; Australia enters recession. Follow all the developments liveSchools reopen across Europe as cases growUS refuses to cooperate with WHO on vaccineScotland rules holidaymakers returning from Greece must isolateFollow updates from Australia 3.06am BST A study of 30,000 people in Iceland has found that the antibodies we make to fight the coronavirus last for at least four months after diagnosis...
Tags: Europe, Science, Greece, Australia, White House, US, UK News, Australia news, US news, Harvard, Infectious Diseases, Brazil, Associated Press, Iceland, Aussies, US National Institutes of Health

Fauci 'Cautiously Optimistic' Vaccine Could Be Available by End of 2020 or Early 2021

Dr. Anthony Fauci, the government's top infectious disease expert, told a House committee on Tuesday he believes "it will be when and not if" there will be a COVID-19 vaccine and that he remains "cautiously optimistic" that some will be ready at the end of the year. From a report: Fauci has returned to Capitol Hill at a fraught moment in the nation's pandemic response, with coronavirus cases rising in about half the states and political polarization competing for attention with public health rec...
Tags: Texas, US, Tech, House, Cambridge, Capitol Hill, Donald Trump, Anthony Fauci, Wall Street Journal, Mike Pence, Department of Health and Human Services, Fauci, Arizona Florida, US National Institutes of Health, Moderna

The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)

The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine. The Cambridge, Massachusetts-based biotech was founded in 2010 with the ambitious goal to develop a new type of medicine. While its platform remains unproven, it is now being tested under the brightest possible spotlight of a pandemic.  Here's the inside story of Moderna's rise, from an offshoot of stem cell research to routinely shattering funding records on its way to biotech's top r...
Tags: Google, Amazon, Microsoft, Navy, California, Washington Post, France, China, US, Trends, Merck, Mit, Harvard, Cambridge, Astrazeneca, Fidelity

This machine-learning upstart trained software to snare online drug dealers. Now it's going after fake coronavirus test equipment peddlers

US govt-funded outfit hopes to kill off web quackery that puts us all at risk Machine-learning software to snare scammers hawking fake COVID-19 test kits on social media is being built by a tiny startup funded by the US National Institutes of Health.…
Tags: US, Software, US National Institutes of Health

Novel antibiotic shows promise in treatment of uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, sponsored the clinical study.
Tags: US National Institutes of Health

Dementia Discovery Fund racks up $350 mln

Dementia Discovery Fund has raised $350 million, beating its $200 million target. DDF’s investors include Bill Gates, AARP, Aegon, Quest Diagnostics and British Patient Capital. Based in Boston and London, DDF focuses on backing companies that develop dementia drugs. PRESS RELEASE LONDON–(BUSINESS WIRE)–The Dementia Discovery Fund (DDF) today announces the completion of its fundraising, with £250 million ($350 million at the time of completion) raised from an influential group of strategic inves...
Tags: UK, London, Boston, US, Trends, Bill Gates, Healthcare, Funds, Grant, Ontario, AARP, Celgene, SAB, Takeda, NFL Players Association, US National Institutes of Health

The extraordinary healing powers of music

The US National Institutes of Health is exploring the relationship between music and the brain.
Tags: News, US National Institutes of Health

New Antibody Attacks 99% of HIV Strains

An anonymous reader quotes a report from BBC: Scientists have engineered an antibody that attacks 99% of HIV strains and can prevent infection in primates. It is built to attack three critical parts of the virus -- making it harder for HIV to resist its effects. The work is a collaboration between the US National Institutes of Health and the pharmaceutical company Sanofi. Our bodies struggle to fight HIV because of the virus' incredible ability to mutate and change its appearance. These varietie...
Tags: Tech, Bbc, Sanofi, US National Institutes of Health, Gary Nabel

Brain researchers in uproar over NIH clinical-trials policy

An open letter to the US National Institutes of Health says that classifying human-behaviour studies as clinical trials creates unnecessary red tape.Nature News doi: 10.1038/nature.2017.22550
Tags: Nih, US National Institutes of Health

Publicly funded research lays critical foundations for private sector

Nearly 10 percent of US National Institutes of Health research grants directly generate a patent, a new study reveals, and more than 30 percent generate articles that are then cited by patents.
Tags: Science, US National Institutes of Health

‘Zombie’ patent fights over mutant mice return

University takes on US National Institutes of Health over animals used for Alzheimer’s research.Nature 543 296 doi: 10.1038/nature.2017.21620
Tags: US National Institutes of Health

Opinion: Gender diversity leads to better science [Psychological and Cognitive Sciences]

Pick up any recent policy paper on women’s participation in science and you will find assurances that gender diversity enhances knowledge outcomes. Universities and science-policy stakeholders, including the European Commission and the US National Institutes of Health, readily subscribe to this argument (1–3). But is there, in fact, a gender-diversity...
Tags: European Commission, Cognitive Sciences, US National Institutes of Health